Principal Financial Group’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3M | Sell |
454,919
-23,945
| -5% | -$751K | 0.01% | 1052 |
|
|
2025
Q1 | $14.2M | Sell |
478,864
-23,993
| -5% | -$712K | 0.01% | 1055 |
|
|
2024
Q4 | $14.8M | Sell |
502,857
-43,461
| -8% | -$1.28M | 0.01% | 1054 |
|
|
2024
Q3 | $17M | Buy |
546,318
+109,206
| +25% | +$3.4M | 0.01% | 940 |
|
|
2024
Q2 | $14.8M | Sell |
437,112
-80,092
| -15% | -$2.71M | 0.01% | 1044 |
|
|
2024
Q1 | $33.6M | Buy |
517,204
+33,868
| +7% | +$2.2M | 0.02% | 627 |
|
|
2023
Q4 | $33M | Sell |
483,336
-2,550
| -0.5% | -$174K | 0.02% | 593 |
|
|
2023
Q3 | $25.2M | Buy |
485,886
+2,129
| +0.4% | +$110K | 0.02% | 686 |
|
|
2023
Q2 | $29M | Buy |
483,757
+29,953
| +7% | +$1.8M | 0.02% | 637 |
|
|
2023
Q1 | $22.4M | Sell |
453,804
-48,179
| -10% | -$2.38M | 0.02% | 780 |
|
|
2022
Q4 | $28.6M | Sell |
501,983
-24,269
| -5% | -$1.39M | 0.02% | 620 |
|
|
2022
Q3 | $24.7M | Buy |
526,252
+226,302
| +75% | +$10.6M | 0.02% | 646 |
|
|
2022
Q2 | $11.2M | Buy |
299,950
+64,405
| +27% | +$2.4M | 0.01% | 1190 |
|
|
2022
Q1 | $7.04M | Buy |
235,545
+1,106
| +0.5% | +$33.1K | ﹤0.01% | 1524 |
|
|
2021
Q4 | $8.03M | Buy |
234,439
+49,514
| +27% | +$1.7M | ﹤0.01% | 1504 |
|
|
2021
Q3 | $6.86M | Buy |
184,925
+7,820
| +4% | +$290K | ﹤0.01% | 1568 |
|
|
2021
Q2 | $6.92M | Buy |
177,105
+53,533
| +43% | +$2.09M | ﹤0.01% | 1609 |
|
|
2021
Q1 | $5.26M | Buy |
+123,572
| New | +$5.26M | ﹤0.01% | 1652 |
|